<bill session="115" type="h" number="2212" updated="2019-04-18T16:07:39Z">
  <state datetime="2017-04-27">REFERRED</state>
  <status>
    <introduced datetime="2017-04-27"/>
  </status>
  <introduced datetime="2017-04-27"/>
  <titles>
    <title type="official" as="introduced">To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.</title>
    <title type="short" as="introduced">CREATES Act of 2017</title>
    <title type="short" as="introduced">CREATES Act of 2017</title>
    <title type="short" as="introduced">Creating and Restoring Equal Access To Equivalent Samples Act of 2017</title>
    <title type="short" as="introduced">Creating and Restoring Equal Access To Equivalent Samples Act of 2017</title>
    <title type="display">CREATES Act of 2017</title>
  </titles>
  <sponsor bioguide_id="M001179"/>
  <cosponsors>
    <cosponsor bioguide_id="B001282" joined="2018-05-03"/>
    <cosponsor bioguide_id="B001290" joined="2018-03-15"/>
    <cosponsor bioguide_id="C001084" joined="2017-04-27"/>
    <cosponsor bioguide_id="C001068" joined="2018-02-08"/>
    <cosponsor bioguide_id="C001048" joined="2018-03-13"/>
    <cosponsor bioguide_id="D000191" joined="2018-05-03"/>
    <cosponsor bioguide_id="D000399" joined="2018-03-13"/>
    <cosponsor bioguide_id="D000533" joined="2018-03-08"/>
    <cosponsor bioguide_id="G000579" joined="2018-02-23"/>
    <cosponsor bioguide_id="G000563" joined="2018-04-17"/>
    <cosponsor bioguide_id="G000576" joined="2018-09-28"/>
    <cosponsor bioguide_id="K000009" joined="2018-02-20"/>
    <cosponsor bioguide_id="K000210" joined="2018-08-10"/>
    <cosponsor bioguide_id="L000563" joined="2018-09-28"/>
    <cosponsor bioguide_id="M001187" joined="2018-02-06"/>
    <cosponsor bioguide_id="N000147" joined="2018-03-08"/>
    <cosponsor bioguide_id="O000170" joined="2018-06-06"/>
    <cosponsor bioguide_id="R000606" joined="2018-08-10"/>
    <cosponsor bioguide_id="R000586" joined="2018-06-06"/>
    <cosponsor bioguide_id="R000592" joined="2018-02-08"/>
    <cosponsor bioguide_id="R000607" joined="2018-02-20"/>
    <cosponsor bioguide_id="S001145" joined="2018-04-17"/>
    <cosponsor bioguide_id="S001170" joined="2018-02-23"/>
    <cosponsor bioguide_id="T000193" joined="2018-03-15"/>
    <cosponsor bioguide_id="W000800" joined="2018-02-06"/>
  </cosponsors>
  <actions>
    <action datetime="2017-04-27">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-04-27" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-04-27">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-04-28">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="" code="HSJU" name="House Judiciary" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="115" relation="identical" number="974"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Civil actions and liability"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
    <term name="Product development and innovation"/>
  </subjects>
  <amendments/>
  <summary date="2017-04-27T04:00:00Z" status="Introduced in House">Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017

This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved drug or biological product if the holder has declined to make available sufficient quantities of the approved drug or product for the developer's testing.</summary>
  <committee-reports/>
</bill>
